Estas terapias han demostrado eficacia al disminuir la concentracin de HbA1c, glucemia plasmtica y glucemia postprandial, mejorando el control glucmico de estos pacientes, sin embargo, los efectos en la mortalidad cardiovascular difieren en los dos grupos farmacolgicos presentes donde la liraglutida, un agonista del receptor GLP-1 (GLP-1R), demostr recientemente en el ensayo clnico denominado LEADER un beneficio cardiovascular, que es equivalente al recientemente constatado por los inhibidores del SGLT-2 4
Dentaltown Ive seen the devastation of xerostomia on the oral cavity
It will cover Ozempic when prescribed for type 2 diabetes management, not weight loss
Nearly a decade ago, a thin, soft-spoken twenty-something woman named Megan walked into my office and presented me with a meticulous hand-written file containing her gastrointestinal history
High costs and challenging side effects havent stopped many people from clamoring to get the drugs, which can help patients lose 20% or more of their body weight